NRIX (Nurix Therapeutics, Inc.) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold NRIX (Nurix Therapeutics, Inc.) with a combined value of $340.18M across 17,932,360 shares. The largest holder is BlackRock, Inc. with a position worth $168.36M (0.00% of their portfolio). 4 funds increased their holdings.
Total Institutional Value
$340.18M
Total Shares Held
17,932,360
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $168.36M | 0.00% | +31.2% |
| 2 | BAKER BROS. ADVISORS LP | $88.37M | 0.52% | +20.0% |
| 3 | Point72 Asset Management, L.P. | $60.93M | 0.07% | +11.8% |
| 4 | CITADEL ADVISORS LLC | $22.52M | 0.00% | +95.9% |